These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22554675)

  • 61. Role of the Fc region in CD70-specific antibody effects on cardiac transplant survival.
    Shariff H; Greenlaw RE; Meader L; Gardner N; Yagita H; Coccia M; Mamode N; Jurcevic S
    Transplantation; 2011 Dec; 92(11):1194-201. PubMed ID: 22089665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.
    Salehi S; Sosa RA; Jin YP; Kageyama S; Fishbein MC; Rozengurt E; Kupiec-Weglinski JW; Reed EF
    Am J Transplant; 2018 May; 18(5):1096-1109. PubMed ID: 29045076
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection.
    Sugarbaker PH; Chang AE
    Transplantation; 1979 Jul; 28(1):60-5. PubMed ID: 377597
    [No Abstract]   [Full Text] [Related]  

  • 64. CCR5 blockade modulates inflammation and alloimmunity in primates.
    Schröder C; Pierson RN; Nguyen BN; Kawka DW; Peterson LB; Wu G; Zhang T; Springer MS; Siciliano SJ; Iliff S; Ayala JM; Lu M; Mudgett JS; Lyons K; Mills SG; Miller GG; Singer II; Azimzadeh AM; DeMartino JA
    J Immunol; 2007 Aug; 179(4):2289-99. PubMed ID: 17675490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients.
    Sicard A; Phares TW; Yu H; Fan R; Baldwin WM; Fairchild RL; Valujskikh A
    Am J Transplant; 2012 Jul; 12(7):1708-19. PubMed ID: 22420367
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Absence of FcγRIII results in increased proinflammatory response in FcγRIII-KO cardiac recipients.
    Erdinc Sunay MM; Fox-Talbot K; Velidedeoglu E; Baldwin WM; Wasowska BA
    Transplantation; 2013 Oct; 96(7):601-8. PubMed ID: 23903009
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alloantibody and transferable suppressor activity induced by cyclosporine and blood transfusions in the rat.
    Jones MC; Power DA; Cunningham C; Stewart KN; Catto GR
    Transplantation; 1988 Nov; 46(5):645-9. PubMed ID: 2973667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular Signature of Antibody-Mediated Chronic Vasculopathy in Heart Allografts in a Novel Mouse Model.
    Tsuda H; Dvorina N; Keslar KS; Nevarez-Mejia J; Valenzuela NM; Reed EF; Fairchild RL; Baldwin WM
    Am J Pathol; 2022 Jul; 192(7):1053-1065. PubMed ID: 35490714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy.
    Goto R; Issa F; Heidt S; Taggart D; Wood KJ
    Transplantation; 2013 Jul; 96(2):139-45. PubMed ID: 24049808
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection.
    Tang JL; Subbotin VM; Antonysamy MA; Troutt AB; Rao AS; Thomson AW
    Transplantation; 2001 Jul; 72(2):348-50. PubMed ID: 11477368
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.
    Cardinal H; Dieudé M; Brassard N; Qi S; Patey N; Soulez M; Beillevaire D; Echeverry F; Daniel C; Durocher Y; Madore F; Hébert MJ
    Am J Transplant; 2013 Apr; 13(4):861-874. PubMed ID: 23432943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.
    Jiang X; Nguyen TT; Tian W; Sung YK; Yuan K; Qian J; Rajadas J; Sallenave JM; Nickel NP; de Jesus Perez V; Rabinovitch M; Nicolls MR
    Am J Transplant; 2015 Jul; 15(7):1768-81. PubMed ID: 25727073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel Targets of Immunosuppression in Transplantation.
    Shin HS; Grgic I; Chandraker A
    Clin Lab Med; 2019 Mar; 39(1):157-169. PubMed ID: 30709504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-intercellular adhesion molecule 1 monomaintenance therapy induced long-term liver allograft survival without chronic rejection.
    Han DK; Hong SK; Yun IH; Yan JJ; Park J; Kim SW; Seok SH; Kim H; Ji G; Choi Y; Lee KW; Suh KS; Yang J; Yi NJ
    Am J Transplant; 2024 Oct; 24(10):1772-1783. PubMed ID: 38561059
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.
    Lin T; Zhou W; Farrar CA; Hargreaves RE; Sheerin NS; Sacks SH
    Am J Pathol; 2006 Apr; 168(4):1241-8. PubMed ID: 16565498
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice.
    Russell PS; Chase CM; Colvin RB
    Transplantation; 1997 Dec; 64(11):1531-6. PubMed ID: 9415552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models.
    Abboud R; Kim S; Staser K; Jayasinghe RG; Lim S; Amatya P; Frye CC; Kopecky B; Ritchey J; Gao F; Lavine K; Kreisel D; DiPersio JF; Choi J
    Front Immunol; 2023; 14():1264496. PubMed ID: 37744381
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hypodermin C improves the survival of kidney allografts.
    Hu A; Wang Y; Yuan H; Wu L; Zheng K
    Transpl Immunol; 2018 Dec; 51():45-49. PubMed ID: 30184470
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Eosinophils are not required for the induction and maintenance of an alloantibody response.
    Cravedi P; Lessman DA; Heeger PS
    Am J Transplant; 2013 Oct; 13(10):2696-702. PubMed ID: 23919628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.